[Caution in therapy of ventricular extrasystole. Staying safe with electrolytes].
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001224:Aspartic Acid / Q000008:administration & dosage*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000401:mortality; D002423:Cause of Death; D004338:Drug Combinations; D016700:Encainide / Q000009:adverse effects* / Q000627:therapeutic use; D005424:Flecainide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011188:Potassium / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents; D004338:Drug Combinations; D001224:Aspartic Acid; D005424:Flecainide; D011188:Potassium; D016700:Encainide